Effect of Tocilizumab Treatment on Patients with Coronavirus Disease 2019 and Bacteremia: A Retrospective Cohort Study

INTRODUCTION: This study aimed to determine if tocilizumab treatment for coronavirus disease 2019 (COVID-19) increases bacteremia and suppresses fever and inflammatory reactants. METHODS: In this single-center, retrospective, observational study, all patients with COVID-19 admitted to our emergency...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwahara, Masaatsu, Kamigaito, Misa, Nitta, Shou, Hasegawa, Kana, Murakami, Hiromoto, Kobayashi, Tomoyuki, Shirai, Kunihiro, Kohama, Keisuke, Hirata, Jun-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775152/
https://www.ncbi.nlm.nih.gov/pubmed/35060111
http://dx.doi.org/10.1007/s40121-022-00592-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775152/
https://www.ncbi.nlm.nih.gov/pubmed/35060111
http://dx.doi.org/10.1007/s40121-022-00592-1

Ejemplares similares